Singapore, March 17 -- Japan-based Murata Manufacturing Co. has successfully commercialised and mass produced "CELLNETTA," the world's firstmetal cell fractionation filter designed for the rapid and precise selection and recovery of target cells from cell suspensionsused in regenerative medicine and cell pharmaceutical research and development.
Target applications include fractionation (selection and recovery), concentration, and filtration in research and development for regenerative medicine technologies or cellular pharmaceuticals, as well as biotechnology across agriculture, forestry, food, and energy industries. The product will be showcased at the 24th Annual Meeting of the Japanese Society for Regenerative Medicine happening March...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.